Amundi

Amundi’s Sage Therapeutics SAGE Stock Holding History

Amundi’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28,327	Closed	-$166K	–	2238
2024 Q4	$166K	Buy	+28,327	New	+$173K	﹤0.01%	1740
2022 Q4	–	Sell	-2,758	Closed	-$114K	–	1969
2022 Q3	$114K	Hold	2,758	–	–	﹤0.01%	1534
2022 Q2	$97K	Hold	2,758	–	–	﹤0.01%	1451
2022 Q1	$99K	Hold	2,758	–	–	﹤0.01%	1471
2021 Q4	$117K	Hold	2,758	–	–	﹤0.01%	1550
2021 Q3	$122K	Sell	2,758 -197,503	-99%	-$9.06M	﹤0.01%	1499
2021 Q2	$11.4M	Buy	+200,261	New	+$14.2M	0.01%	808

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return